DK1301526T3 - Fremgangsmåde til oxidation til fremstilling af mellemproduktet 6.alpha.,9alpha.-difluor-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-on 17.beta-carboxylsyre - Google Patents

Fremgangsmåde til oxidation til fremstilling af mellemproduktet 6.alpha.,9alpha.-difluor-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-on 17.beta-carboxylsyre

Info

Publication number
DK1301526T3
DK1301526T3 DK01949791T DK01949791T DK1301526T3 DK 1301526 T3 DK1301526 T3 DK 1301526T3 DK 01949791 T DK01949791 T DK 01949791T DK 01949791 T DK01949791 T DK 01949791T DK 1301526 T3 DK1301526 T3 DK 1301526T3
Authority
DK
Denmark
Prior art keywords
alpha
beta
oxidation
9alpha
androst
Prior art date
Application number
DK01949791T
Other languages
English (en)
Inventor
Frederick David Albinson
Steven John Coote
John Malcolm Robinson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DK1301526T3 publication Critical patent/DK1301526T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK01949791T 2000-07-21 2001-07-20 Fremgangsmåde til oxidation til fremstilling af mellemproduktet 6.alpha.,9alpha.-difluor-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-on 17.beta-carboxylsyre DK1301526T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0017988.7A GB0017988D0 (en) 2000-07-21 2000-07-21 Novel process
PCT/GB2001/003289 WO2002008243A1 (en) 2000-07-21 2001-07-20 Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid

Publications (1)

Publication Number Publication Date
DK1301526T3 true DK1301526T3 (da) 2008-10-06

Family

ID=9896132

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01949791T DK1301526T3 (da) 2000-07-21 2001-07-20 Fremgangsmåde til oxidation til fremstilling af mellemproduktet 6.alpha.,9alpha.-difluor-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-on 17.beta-carboxylsyre

Country Status (26)

Country Link
US (1) US20040043974A1 (da)
EP (1) EP1301526B1 (da)
JP (1) JP2004504403A (da)
KR (1) KR100787293B1 (da)
CN (1) CN1315864C (da)
AT (1) ATE398628T1 (da)
AU (2) AU2001270906B2 (da)
BR (1) BR0110430A (da)
CA (1) CA2406963A1 (da)
CY (1) CY1108553T1 (da)
CZ (1) CZ302592B6 (da)
DE (1) DE60134472D1 (da)
DK (1) DK1301526T3 (da)
ES (1) ES2307628T3 (da)
GB (1) GB0017988D0 (da)
HK (1) HK1056179B (da)
HU (1) HUP0301108A3 (da)
IL (2) IL152348A0 (da)
MX (1) MXPA02010967A (da)
NO (1) NO324836B1 (da)
NZ (1) NZ522083A (da)
PL (1) PL206652B1 (da)
PT (1) PT1301526E (da)
SI (1) SI1301526T1 (da)
WO (1) WO2002008243A1 (da)
ZA (1) ZA200208372B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
IL150654A (en) 2002-07-09 2006-12-10 Ori Lerman Method for acid isolation 6α, 9α - difluoro - ß, 17α11 - dihydroxy - 16α - methylfargana - 3 - oxo - 1, 4 - diene - 17ß - carboxylate
EP1611149A1 (en) * 2003-04-04 2006-01-04 Alpharma APS Process for the preparation of steroidal carbothioic acid derivatives and intermediates
EP1466920A1 (en) * 2003-04-04 2004-10-13 Alpharma APS Process for the preparation of steroidal 17 beta-carbothioates
EP1526139A1 (en) * 2003-10-24 2005-04-27 S.N.I.F.F. Italia S.P.A. A process for preparing highly pure androstane 17-beta-carboxylic acids and androstane 17-beta-carbothioic acid fluoromethyl esters
GB0612027D0 (en) 2006-06-16 2006-07-26 Glaxo Group Ltd Novel process
NO331891B1 (no) * 2007-03-20 2012-04-30 Clavis Pharma Asa Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS
PT105139B (pt) * 2010-06-01 2013-01-29 Hovione Farmaciencia S A Método para a monofluorometilação de substratos orgânicos para preparação de compostos orgânicos biologicamente activos
EP2611821A2 (en) 2010-09-01 2013-07-10 Cadila Healthcare Limited Process for preparing fluticasone propionate/furoate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636010A (en) * 1968-12-23 1972-01-18 Ciba Geigy Corp Esters of steroid-17-carboxylic acids
US4198336A (en) * 1978-04-05 1980-04-15 Syntex (U.S.A.) Inc. Chemical process for preparing androsta-4-ene 17α-carboxylic acids
US4263289A (en) * 1978-04-05 1981-04-21 Syntex (U.S.A.) Inc. Thio etianic acid derivatives
US4188385A (en) * 1978-04-05 1980-02-12 Syntex (U.S.A.) Inc. Thioetianic acid derivatives
NL187577C (nl) * 1978-04-05 1991-11-18 Sibla Srl 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen.
GB2088877B (en) * 1980-02-15 1984-07-04 Glaxo Group Ltd Androstane 17 carbothioates
US5646136A (en) * 1994-01-04 1997-07-08 Duke University Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids
SK89198A3 (en) * 1995-12-29 1999-03-12 Glaxo Group Ltd Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives
US20020133032A1 (en) * 2000-02-25 2002-09-19 Jufang Barkalow Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods
ATE328744T1 (de) * 2000-04-04 2006-06-15 Celanese Int Corp Tintenaufnehmende zusammensetzung, die polyvinylalkohol mit gepfropften amingruppen enthaelt
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions

Also Published As

Publication number Publication date
IL152348A0 (en) 2003-05-29
JP2004504403A (ja) 2004-02-12
US20040043974A1 (en) 2004-03-04
NO20025054L (no) 2002-11-05
DE60134472D1 (de) 2008-07-31
HUP0301108A3 (en) 2008-04-28
SI1301526T1 (sl) 2008-10-31
EP1301526B1 (en) 2008-06-18
CN1437610A (zh) 2003-08-20
AU7090601A (en) 2002-02-05
CY1108553T1 (el) 2014-04-09
PL359462A1 (en) 2004-08-23
CZ20023472A3 (cs) 2003-04-16
NO324836B1 (no) 2007-12-17
CZ302592B6 (cs) 2011-07-27
GB0017988D0 (en) 2000-09-13
KR20030028736A (ko) 2003-04-10
ATE398628T1 (de) 2008-07-15
NZ522083A (en) 2004-06-25
AU2001270906B2 (en) 2005-10-13
HUP0301108A2 (hu) 2003-08-28
HK1056179A1 (en) 2004-02-06
CA2406963A1 (en) 2002-01-31
CN1315864C (zh) 2007-05-16
HK1056179B (zh) 2009-07-17
ZA200208372B (en) 2004-02-11
IL152348A (en) 2008-08-07
EP1301526A1 (en) 2003-04-16
KR100787293B1 (ko) 2007-12-20
WO2002008243A1 (en) 2002-01-31
ES2307628T3 (es) 2008-12-01
PT1301526E (pt) 2008-09-09
MXPA02010967A (es) 2003-03-27
PL206652B1 (pl) 2010-09-30
BR0110430A (pt) 2003-07-08
NO20025054D0 (no) 2002-10-21

Similar Documents

Publication Publication Date Title
DK1301526T3 (da) Fremgangsmåde til oxidation til fremstilling af mellemproduktet 6.alpha.,9alpha.-difluor-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-on 17.beta-carboxylsyre
DE69512797D1 (en) Prostaglandin-synthase hemmer
MXPA03007853A (es) Metodo para la sintesis de 2',3'-didesoxi-2',3'-dideshidronucleosidos.
DE69932864D1 (de) Neue Fettsäureanaloge zur Behandlung des Bluthochdrucks
HK1078857A1 (en) Intermediates for the production of beraprost and its salts
DK1255747T3 (da) Syntese af 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-on
ATE359272T1 (de) Verfahren zur herstellung von 3-hydroxy-n-1,6-
NO20023276D0 (no) Fremgangsmåte til å fremstille betulinsyre
ATE457972T1 (de) Verfahren zur herstellung von 7-amino-syn-3,5- dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
DE60105441D1 (de) Verfahren zur herstellung von pantoprazol und zwischenprodukte dieses verfahrens
ATE281434T1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
FI960301A (fi) Nikkelitön hemoglobiini ja menetelmät sellaisen hemoglobiinin tuottamiseksi
JO2433B1 (en) Preparation of heterocyclic lindane landscapes
ATE302749T1 (de) Verfahren zur herstellung von 5-aminosalicylsäure
EA200300400A1 (ru) 17α-ФТОРАЛКИЛСТЕРОИДЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ЭТИ СОЕДИНЕНИЯ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
SE0201938D0 (sv) New process
DE60107292D1 (de) Verfahren zur herstellung von (+)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidin
ID27440A (id) Proses untuk menyiapkan penengah-penengah
ATE299862T1 (de) Verfahren zur herstellung von ketiminen
DE60014103D1 (de) Verfahren zur herstellung von debromohymenialdisin und deren analogen
AU7851201A (en) Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof
ATE309226T1 (de) Verfahren zur herstellung von fluconazole und kristallmodifikationen davon
DE60105171D1 (de) Verfahren zur herstellung von gehinderten phosphiten
UA32065A (uk) Спосіб підготовки води
HU0001287D0 (en) New intermediate and process for its production